𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase I trial of sunitinib and gemcitabine in patients with advanced solid tumors

✍ Scribed by Joanna M. Brell, Smitha S. Krishnamurthi…


Book ID
120776506
Publisher
Springer
Year
2012
Tongue
English
Weight
177 KB
Volume
70
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Phase I clinical trial of bortezomib in
✍ David P. Ryan; Leonard J. Appleman; Thomas Lynch; Jeffrey G. Supko; Panagiotis F 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 2 views

## Abstract ## BACKGROUND. Bortezomib is the first proteasome inhibitor to show preliminary evidence of activity against solid tumors. Findings from preclinical studies prompted a Phase I trial to determine the maximum tolerated dose (MTD) and dose‐limiting toxicities (DLTs) of bortezomib in combi